COVID-19 IgG/IgM Rapid Tests

Podstawy Działania

The 2019-nCoV IgG/IgM Rapid Test (Whole Blood/Serum/Plasma) is a qualitative membrane-based immunoassay for the detection of IgG and IgM antibodies to 2019-nCoV in whole blood, serum or plasma specimen. This test consists of two components, an IgG component and an IgM component. In the IgG component, anti-human IgG is coated in IgG test line region. During testing, the specimen reacts with 2019-nCoV antigen-coated particles in the test cassette. The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgG in IgG test line region, if the specimen contains IgG antibodies to 2019-nCoV. A colored line will appear in IgG test line region as a result of this. Similarly, anti-human IgM is coated in IgM test line region and if specimen contains IgM antibodies to 2019-nCoV, the conjugate-specimen complex reacts with anti-human IgM. A colored line appears in IgM test line region as a result.

Właściwości Testu

The 2019-nCoV IgG/IgM Rapid Test (Whole Blood/Serum/Plasma) was compared with a leading commercial PCR; the results show that 2019-nCoV IgG/IgM Rapid Test (Whole Blood/Serum/Plasma) has a high ability of measuring the proportion of actual positives, sensitivity, and ability of measuring the proportion of actual negatives, namely specificity.  

What is in the Package?

Testy pakowane są zwykle w opakowaniach po 50 zestawów, zawierające takie niezbędne przedmioty jak kaseta testowa, igły do pobrania próbki czy substancje katalizującą.

rapid test

Why is it worth to trust us?

The Novazym’s COVID-19 rapid test had been registered as the solution to identify the SARS-COV-2 viruses’ presence, by the polish institute URPL. Clinical studies were performed with the criteria corresponding to international standards, including ISO/IEC 17025 and ISO 15189. Results of this studies are available to download :